DE69925710D1 - Verfahren zum screening der apoptosis und necrose - Google Patents

Verfahren zum screening der apoptosis und necrose

Info

Publication number
DE69925710D1
DE69925710D1 DE69925710T DE69925710T DE69925710D1 DE 69925710 D1 DE69925710 D1 DE 69925710D1 DE 69925710 T DE69925710 T DE 69925710T DE 69925710 T DE69925710 T DE 69925710T DE 69925710 D1 DE69925710 D1 DE 69925710D1
Authority
DE
Germany
Prior art keywords
necrosis
apoptotic
pro
necrotic
screening apoptosis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69925710T
Other languages
English (en)
Inventor
Thomas Harr
Alessandro Strebel
Peter Erb
Sinuhe Hahn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HEMOLYTICS AG WITTERSWIL
Original Assignee
HEMOLYTICS AG WITTERSWIL
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HEMOLYTICS AG WITTERSWIL filed Critical HEMOLYTICS AG WITTERSWIL
Application granted granted Critical
Publication of DE69925710D1 publication Critical patent/DE69925710D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5011—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing antineoplastic activity
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/43504—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates
    • G01N2333/43595—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from invertebrates from coelenteratae, e.g. medusae
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2510/00—Detection of programmed cell death, i.e. apoptosis
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
DE69925710T 1998-01-12 1999-01-12 Verfahren zum screening der apoptosis und necrose Expired - Lifetime DE69925710D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98100369A EP0928968A1 (de) 1998-01-12 1998-01-12 Verfahren zum Screening der Apoptosis und Necrose
PCT/IB1999/000030 WO1999035493A1 (en) 1998-01-12 1999-01-12 Screening method for apoptosis and necrosis

Publications (1)

Publication Number Publication Date
DE69925710D1 true DE69925710D1 (de) 2005-07-14

Family

ID=8231252

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69925710T Expired - Lifetime DE69925710D1 (de) 1998-01-12 1999-01-12 Verfahren zum screening der apoptosis und necrose

Country Status (7)

Country Link
US (2) US6723567B1 (de)
EP (2) EP0928968A1 (de)
JP (1) JP2002500863A (de)
AT (1) ATE297553T1 (de)
CA (1) CA2317463A1 (de)
DE (1) DE69925710D1 (de)
WO (1) WO1999035493A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050202098A1 (en) 2001-01-31 2005-09-15 Tolaren Disease therapy using dying or dead cells
WO2003067255A1 (en) * 2002-02-04 2003-08-14 Hemolytics Ag High throughput screening method for compounds with non-, pro-, or anti-apoptotic or proliferative or necrotic activity
DE10318048A1 (de) * 2003-04-17 2004-11-04 Axaron Bioscience Ag Nicht fluoreszierende, durch Proteolyse zur Fluoreszenz aktivierbare Reporterproteine und ihre Verwendung zur Detektion Protease-abhängiger Ereignisse
CA2577196C (en) * 2004-08-23 2016-01-12 Johannes Herkel Peptide inhibitors for mediating stress responses
US7897401B2 (en) * 2005-11-29 2011-03-01 University Of Maryland, College Park Control of apoptosis by controlling the propensity of ceramide channel formation
CN102719465B (zh) * 2011-03-29 2014-01-08 复旦大学 可诱导性组织特异性表达载体及其用途
US20140088017A1 (en) 2011-05-23 2014-03-27 Yeda Research And Development Co., Ltd. Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
US11912790B2 (en) 2018-07-11 2024-02-27 Immunity Pharma Ltd. Peptide compounds and therapeutic uses of same
IL272074A (en) 2020-01-15 2021-07-29 Immunity Pharma Ltd Peptide compounds and their use in methods of treating diseases

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2824155B2 (ja) * 1994-04-11 1998-11-11 ネクシンズ・リサーチ・ベー・ブイ 試料中の又は試料からアポトーシス細胞を検出し及び／又は場合により定量し及び／又は分離するための方法
US5958713A (en) * 1995-01-31 1999-09-28 Novo Nordisk A/S Method of detecting biologically active substances by using green fluorescent protein
CA2232727C (en) * 1995-09-22 2002-03-26 Novo Nordisk A/S Novel variants of green fluorescent protein, gfp
WO1997014812A2 (en) * 1995-10-16 1997-04-24 Chiron Corporation Method of screening for factors that modulate gene expression
EP0806668B1 (de) * 1996-05-10 2002-07-31 Becton, Dickinson and Company Verfahren und Vorrichtung zum Nachweis eines malignen Potentials in Gewebezellen
US6037461A (en) * 1997-05-20 2000-03-14 Thomas Jefferson University FADD-like anti-apoptotic molecules, methods of using the same, and compositions for and methods of making the same
US5945291A (en) * 1997-11-10 1999-08-31 Coulter International Corp. Method for distinguishing viable, early apoptotic, late apoptotic, and necrotic cells

Also Published As

Publication number Publication date
JP2002500863A (ja) 2002-01-15
ATE297553T1 (de) 2005-06-15
WO1999035493A1 (en) 1999-07-15
US6723567B1 (en) 2004-04-20
EP0928968A1 (de) 1999-07-14
CA2317463A1 (en) 1999-07-15
EP1047937B1 (de) 2005-06-08
US20040166545A1 (en) 2004-08-26
EP1047937A1 (de) 2000-11-02

Similar Documents

Publication Publication Date Title
DK0868519T3 (da) Diagnose og behandling af AUR-1- og/eller AUR-2-relaterede lidelser
DE69925710D1 (de) Verfahren zum screening der apoptosis und necrose
IT8421007A0 (it) Procedimento e composizione per il mantenimento e la riparazione disuperfici contenenti asfalto e gomma.
BR9915679A (pt) Composições e métodos para aumentar a mineralização óssea
DK1051500T3 (da) Diagnose og behandling af AUR1- og/eller AUR2-relaterede sygdomme
DK1012274T3 (da) Dödsdomæneholdig receptor-4 (DR4: dödsreceptor 4), medlem af TNF-receptorsuperfamilien og som binder til TRAIL (Apo-2L)
ATE294164T1 (de) Fluoreszenzfarbstoffe zum festphasen- und flüssigphasen-screening
ATE318905T1 (de) Homologe des tie-rezeptortyrosinekinase liganden
DE59001849D1 (de) Verfahren und vorrichtung zum betrieb einer kaelteanlage.
MX9203469A (es) Molecula de adherencia intercelular-2 y sus ligandos de fijacion.
DE69906835T2 (de) Apparat zur Vermessung von Mikrooberflächen
DE69822510D1 (de) Identifizierung und charakterisierung von interagierenden molekülen
NO962188L (no) Nye apoptose-modulerende proteiner, DNA som koder for proteinene og fremgangsmåter for anvendelse derav
ATE536372T1 (de) Verfahren zur hoher expression der aktiven form von lymphotoxin-beta-rezeptor-immunglobulin fusionsproteinen, und deren reinigung
ATE382148T1 (de) Antikörper für apoptosemarker und anwendungsverfahren
DE69429085T2 (de) Verfahren zur Differenzierung der Quelle okkulter gastrointestinaler Blutungen
ATE488589T1 (de) Transkriptionaler intermediärfaktor 2
DK0643719T3 (da) Nukleinsyresekvenser, som koder for eller er komplementære til nukleinsyresekvenser, som koder for interleukin 9-receptor
ATE469238T1 (de) Verwendung von fluor-nmr zum screening mit hohem durchsatz
DK1342729T3 (da) Antistoffer og antisense-molekyler for G-koblet receptor der udviser selektiv affinitet for ATP
DE3170808D1 (de) Desulfurising agent
DE58906749D1 (de) Verwendung von feststoffen als antiblockadditive für markierflüssigkeiten.
ATE195151T1 (de) Verfahren zur bewertung von substanzen zum steigen bzw. zur modifizierung der apc-aktivität
DE69834813D1 (de) Parvovirus-Vektoren und deren Verwendung
FR2815557B1 (fr) Appareil de tamisage de materiau pulverulent dit "floc", ou de paillettes, recupere(es) apres une premiere utilisation

Legal Events

Date Code Title Description
8332 No legal effect for de